[ad_1]
The US pharmaceutical company, along with its BioNTech SE partners, says the vaccine is effective for people of all ages and ethnic backgrounds, and no safety concerns have been identified so far. Almost 44,000 people participated in the study. volunteers.
This information is another hopeful news about the vaccine that has been published recently.
“The results of the study are an important step in this historic eight-month journey to develop a vaccine that could help end this devastating pandemic,” said Albert Bourla, CEO of Pfizer.
The potential vaccine developed by Moderna Inc. is also effective, as test data published earlier this week demonstrated. The third vaccine developer, AstraZeneca Plc and the University of Oxford, will also present the results of the trial shortly.
Data from Pfizer-BioNTech shows that a total of 170 volunteers became ill with COVID-19. Eight subjects received the vaccine and another 162 cases from the placebo group.
The vaccine helps prevent complications from the disease, the analysis revealed: Nine out of 10 patients in the placebo group were seriously ill. The effectiveness of the vaccine in people over 65 is more than 94 percent, the developers of the vaccine are satisfied.
Most of the participants who received the vaccine tolerated it well. 3.7% complained of severe fatigue after the second of the two injections. volunteers, but this was the only side effect that occurred in more than 2% of patients. people.
Last week it was reported that a coronavirus vaccine developed by Pfizer Inc. and BioNTech SE prevented more than 90 percent of the disease. Infections
“This is the best news for the world, the United States and public health,” said William Gruber, senior vice president of clinical research and vaccine development at Pfizer, last week. The results exceeded even the highest expectations, he admitted.
The effectiveness of the first vaccines was expected to be between 60 and 70%, “more than 90%. it’s an incredible result, ”said Ugur Sahin, CEO of BioNTech.
“We have seen that COVID-19 can be controlled,” Sahin said in an interview. “All in all, it is a true scientific victory.”
[ad_2]
